SE385123B - Sett att framstella racemisk eller optiskt aktiv 13beta-etyl-17alfa-etynyl-gon-4-en-3-on-17beta-ol - Google Patents

Sett att framstella racemisk eller optiskt aktiv 13beta-etyl-17alfa-etynyl-gon-4-en-3-on-17beta-ol

Info

Publication number
SE385123B
SE385123B SE7307341A SE7307341A SE385123B SE 385123 B SE385123 B SE 385123B SE 7307341 A SE7307341 A SE 7307341A SE 7307341 A SE7307341 A SE 7307341A SE 385123 B SE385123 B SE 385123B
Authority
SE
Sweden
Prior art keywords
17alfa
13beta
17beta
gon
ethynyl
Prior art date
Application number
SE7307341A
Other languages
English (en)
Swedish (sv)
Inventor
S Solyom
L Toldy
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HUGO001205 external-priority patent/HU165356B/hu
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE385123B publication Critical patent/SE385123B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0088Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016Oximes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
SE7307341A 1972-05-26 1973-05-24 Sett att framstella racemisk eller optiskt aktiv 13beta-etyl-17alfa-etynyl-gon-4-en-3-on-17beta-ol SE385123B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUGO001205 HU165356B (xx) 1972-05-26 1972-05-26
HUGO001225 1972-05-26

Publications (1)

Publication Number Publication Date
SE385123B true SE385123B (sv) 1976-06-08

Family

ID=26318475

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7307341A SE385123B (sv) 1972-05-26 1973-05-24 Sett att framstella racemisk eller optiskt aktiv 13beta-etyl-17alfa-etynyl-gon-4-en-3-on-17beta-ol

Country Status (9)

Country Link
JP (1) JPS5139217B2 (xx)
AT (1) AT348151B (xx)
BG (1) BG25985A3 (xx)
CS (1) CS163703B2 (xx)
DD (1) DD103894A5 (xx)
DK (1) DK133048C (xx)
NL (1) NL7306609A (xx)
RO (1) RO70322A (xx)
SE (1) SE385123B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5196004U (xx) * 1975-01-30 1976-08-02
US4027019A (en) * 1975-07-24 1977-05-31 Ortho Pharmaceutical Corporation 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method
JPS5752103Y2 (xx) * 1975-12-24 1982-11-12
JPS53110907U (xx) * 1977-02-12 1978-09-05
HUP0301982A2 (hu) * 2003-06-30 2005-04-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás nagy tisztaságú d-(17alfa)-13-etil-17-hidroxi-18,19-dinor-pregn-4-én-20-in-3-on-oxim előállítására
US7816546B2 (en) 2003-06-30 2010-10-19 Richter Gedeon Vegyeszeti Gyar Rt. Process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime
JP6125547B2 (ja) * 2013-04-24 2017-05-10 あすか製薬株式会社 無定形レボノルゲストレル、固体分散体及びそれらの製造方法

Also Published As

Publication number Publication date
RO70322A (ro) 1982-10-26
JPS4948651A (xx) 1974-05-11
JPS5139217B2 (xx) 1976-10-26
CS163703B2 (xx) 1975-11-07
DD103894A5 (xx) 1974-02-12
DK133048C (da) 1976-08-16
DK133048B (da) 1976-03-15
ATA457973A (de) 1978-06-15
BG25985A3 (xx) 1979-01-12
NL7306609A (xx) 1973-11-28
AT348151B (de) 1979-02-12

Similar Documents

Publication Publication Date Title
SE398876B (sv) Sett att framstella basiska 1,4-dihydropyridinkarbonsyraestrar
SE417516B (sv) Forfarande for framstellning av racemiska eller optiskt aktiva piperazinderivat
NO144223C (no) Fremgangsmaate til fremstilling av strekkbart papir
SE392563B (sv) Sett att framstella kottersettningsmedel
BE798046A (fr) Esters de phenyl-indane
SU437291A3 (ru) Способ получения рацемических или оптически активных производных пиперазина
BE799254A (fr) Esters partiels
SE413245B (sv) Forfarande for framstellning av optiskt aktiv (+)-lakton- eller -tiolakton-forening
SE385123B (sv) Sett att framstella racemisk eller optiskt aktiv 13beta-etyl-17alfa-etynyl-gon-4-en-3-on-17beta-ol
SE391274B (sv) Sett att framstella greddersettningsmedel
SE397190B (sv) Sett att framstella substituerade dibensocykloheptener
NO147644C (no) Fremgangsmaate for fremstilling av 6-amino-penicillansyre
AT326702B (de) Mikrokapseln
DE2213755B2 (de) Mikrokapseln
AR196894A1 (es) Estabilizador optico
SE404192B (sv) Sett att framstella 3 beta-cykloalkyloxi-16 alfa-cyanopregn-5-en-20-oner
DK135312B (da) Fremgangsmåde til fremstilling af optisk aktiv dihydrochrysanthemolacton.
DK132028B (da) Analogifremgangsmåde til fremstilling af en racemisk eller optisk aktiv penicillinforbindelse eller et salt heraf.
TR17286A (tr) Ueretanlarin imaline mahsus usul
BE802279A (fr) Penicillines
DK125324B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive sulfamoylpyrimidiner.
DK142312C (da) Fremgangsmaade til fremstilling af optisk aktive bicykloalkanderivater
DK131939C (da) Analogifremgangsmade til fremstilling af racemiske eller optisk aktive fluorsubstituerede alfa-azidobenzylpenicilliner
SE405559B (sv) Sett att loda och lod for utforande av settet
DK146717C (da) Fremgangsmaade til fremstilling af optisk aktive indan- eller naphthalenderivater